DAVID WILSON

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Neuphoria Therapeutics Inc.

Filing Date Source Excerpt
2024-11-12 David Wilson Includes (i) 251,939 shares and (ii) 300,000 shares that Mr. Wilson has the right to acquire pursuant to options that are exercisable as of October 31, 2024, or will become exercisable within 60 days of such date.

Data sourced from SEC filings. Last updated: 2026-02-03